Actionable news
All posts from Actionable news
Actionable news in NVS: NOVARTIS AG,

OptiMed Specialty Pharmacy to Distribute Cosentyx

KALAMAZOO, MI, Apr 22, 2016 (Marketwired via COMTEX) -- OptiMed Specialty Pharmacy has been selected to dispense the limited distribution drug Cosentyx (secukinumab) manufactured by Novartis Pharmaceutical. Cosentyx is a biologic product that is FDA approved to treat adults with any of the following autoimmune inflammatory disorders: moderate to severe plaque psoriasis, active psoriatic arthritis, or active ankylosing spondylitis.

Cosentyx is the first biologic product to target interleukin 17A (IL-17A) in order to reduce inflammation. The drug is given by patient self-injection and is highly effective in improving patient symptoms and enhancing quality of life.

OptiMed Specialty Pharmacy provides patients with specialty medications, like Cosentyx, along with...